INR 273.3
(0.64%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 764.96 Million INR | -4.17% |
2022 | 798.28 Million INR | 34.27% |
2021 | 594.53 Million INR | -12.78% |
2020 | 681.64 Million INR | -29.44% |
2019 | 966.01 Million INR | 20.68% |
2018 | 800.48 Million INR | 6.02% |
2017 | 755.06 Million INR | 25.69% |
2016 | 600.74 Million INR | -30.0% |
2015 | 858.22 Million INR | -28.32% |
2014 | 1.19 Billion INR | -2.61% |
2013 | 1.22 Billion INR | -5.53% |
2012 | 1.3 Billion INR | -2.57% |
2011 | 1.33 Billion INR | 144.14% |
2010 | 547.07 Million INR | -49.53% |
2009 | 1.08 Billion INR | -2.64% |
2008 | 1.11 Billion INR | 22.02% |
2007 | 912.42 Million INR | 34.53% |
2006 | 678.22 Million INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 717.54 Million INR | 0.0% |
2023 Q2 | 811.07 Million INR | 0.0% |
2023 Q4 | 764.96 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 764.96 Million INR | -4.17% |
2023 Q3 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 798.28 Million INR | 0.0% |
2022 Q2 | 634.95 Million INR | 0.0% |
2022 FY | 798.28 Million INR | 34.27% |
2022 Q1 | - INR | -100.0% |
2021 FY | 594.53 Million INR | -12.78% |
2021 Q4 | 594.53 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 510.68 Million INR | 0.0% |
2020 Q4 | 681.64 Million INR | 0.0% |
2020 FY | 681.64 Million INR | -29.44% |
2020 Q2 | 752.66 Million INR | 0.0% |
2019 Q4 | 966.01 Million INR | 0.0% |
2019 FY | 966.01 Million INR | 20.68% |
2019 Q2 | 751.3 Million INR | 0.0% |
2018 Q4 | 800.48 Million INR | 0.0% |
2018 FY | 800.48 Million INR | 6.02% |
2017 FY | 755.06 Million INR | 25.69% |
2017 Q4 | 755.06 Million INR | 0.0% |
2017 Q2 | 641.8 Million INR | 0.0% |
2016 FY | 600.74 Million INR | -30.0% |
2016 Q4 | 855.23 Million INR | 0.0% |
2016 Q2 | 863.19 Million INR | 0.0% |
2015 FY | 858.22 Million INR | -28.32% |
2015 Q2 | 1.13 Billion INR | 0.0% |
2015 Q4 | 858.22 Million INR | 0.0% |
2014 Q4 | 1.19 Billion INR | 0.0% |
2014 FY | 1.19 Billion INR | -2.61% |
2013 FY | 1.22 Billion INR | -5.53% |
2012 FY | 1.3 Billion INR | -2.57% |
2012 Q4 | 1.3 Billion INR | 0.0% |
2012 Q2 | 1.17 Billion INR | 0.0% |
2011 FY | 1.33 Billion INR | 144.14% |
2010 FY | 547.07 Million INR | -49.53% |
2009 FY | 1.08 Billion INR | -2.64% |
2008 FY | 1.11 Billion INR | 22.02% |
2007 FY | 912.42 Million INR | 34.53% |
2006 FY | 678.22 Million INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Ajanta Pharma Limited | -954.9 Million INR | 180.109% |
Amrutanjan Health Care Limited | -248.79 Million INR | 407.47% |
Sigachi Industries Limited | 859.94 Million INR | 11.046% |
Bal Pharma Limited | 1.26 Billion INR | 39.46% |
Ind-Swift Laboratories Limited | -4.15 Billion INR | 118.419% |
Medico Remedies Limited | 78.67 Million INR | -872.282% |
Lasa Supergenerics Limited | 205.79 Million INR | -271.703% |
Venus Remedies Limited | -267.7 Million INR | 385.753% |
Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 181.223% |
Alpa Laboratories Limited | 35.36 Million INR | -2063.171% |
Nectar Lifesciences Limited | 6.15 Billion INR | 87.576% |
Shilpa Medicare Limited | 9.06 Billion INR | 91.566% |
Aarti Drugs Limited | 5.54 Billion INR | 86.213% |
Lupin Limited | 17.19 Billion INR | 95.551% |
Aurobindo Pharma Limited | 3.69 Billion INR | 79.288% |
Zydus Lifesciences Limited | 3.91 Billion INR | 80.446% |
Windlas Biotech Limited | -273.04 Million INR | 380.165% |
Suven Life Sciences Limited | -1.63 Billion INR | 146.853% |
Eris Lifesciences Limited | 13.8 Billion INR | 94.459% |
Valiant Laboratories Limited | -295.03 Million INR | 359.281% |
J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 72.885% |
Solara Active Pharma Sciences Limited | 10.02 Billion INR | 92.372% |
Ipca Laboratories Limited | 11.41 Billion INR | 93.299% |
Bliss GVS Pharma Limited | -1.15 Billion INR | 166.073% |
Achyut Healthcare Limited | -3.74 Million INR | 20520.769% |
Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 101.056% |
Bajaj HealthCare Limited | 3.29 Billion INR | 76.812% |
RPG Life Sciences Limited | -364.7 Million INR | 309.751% |
Mankind Pharma Limited | -9.9 Billion INR | 107.721% |
Laurus Labs Limited | 24.38 Billion INR | 96.863% |
Piramal Pharma Limited | 42.27 Billion INR | 98.191% |
Syncom Formulations (India) Limited | 46.21 Million INR | -1555.368% |
Torrent Pharmaceuticals Limited | 31.83 Billion INR | 97.597% |
Alembic Pharmaceuticals Limited | 3.86 Billion INR | 80.213% |
Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 117.851% |
Unichem Laboratories Limited | 931.91 Million INR | 17.915% |
Sequent Scientific Limited | 4.17 Billion INR | 81.693% |
Novartis India Limited | -5.89 Billion INR | 112.985% |
Wanbury Limited | 1.1 Billion INR | 30.827% |
Suven Pharmaceuticals Limited | 144.97 Million INR | -427.647% |
Wockhardt Limited | 18.27 Billion INR | 95.813% |
Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 155.036% |
Jubilant Pharmova Limited | 27.07 Billion INR | 97.174% |
Glenmark Life Sciences Limited | -2.84 Billion INR | 126.91% |
Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 94.076% |
Divi's Laboratories Limited | -39.77 Billion INR | 101.923% |
NATCO Pharma Limited | -5.81 Billion INR | 113.15% |
Gufic Biosciences Limited | 3.19 Billion INR | 76.052% |
IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 169.46% |
Ind-Swift Limited | 9.5 Billion INR | 91.955% |
Procter & Gamble Health Limited | -2.34 Billion INR | 132.579% |
FDC Limited | -57.75 Million INR | 1424.564% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 60.425% |
Granules India Limited | 9.28 Billion INR | 91.763% |
Medicamen Biotech Limited | 160.31 Million INR | -377.159% |
Alkem Laboratories Limited | -1.6 Billion INR | 147.531% |
AstraZeneca Pharma India Limited | -5.01 Billion INR | 115.261% |
Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 4247.035% |
Brooks Laboratories Limited | 49.48 Million INR | -1445.846% |
Megasoft Limited | 1.28 Billion INR | 40.495% |
ZIM Laboratories Limited | 983.6 Million INR | 22.229% |
Strides Pharma Science Limited | 23.25 Billion INR | 96.711% |
Neuland Laboratories Limited | -214.05 Million INR | 457.362% |
Morepen Laboratories Limited | -231.17 Million INR | 430.903% |
Hikal Limited | 7.96 Billion INR | 90.398% |
Indoco Remedies Limited | 6.47 Billion INR | 88.188% |
Aarti Pharmalabs Limited | 2.61 Billion INR | 70.712% |
Kilitch Drugs (India) Limited | 120.03 Million INR | -537.261% |
Mangalam Drugs & Organics Limited | 975.81 Million INR | 21.608% |
Hester Biosciences Limited | 2.29 Billion INR | 66.606% |